NEW YORK, July 5 - Genomic Solutions said Thursday it expected its second-quarter revenues to be lower than it had initially forecast, because some customers had postponed their orders and because the economy is beginning to slow.

The company expects revenues for the quarter to total between $4.5 and $4.6 million, largely unchanged from the company's second-quarter 2000 revenues of $4.5 million. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.